plectranthus amboinicus
Botanicalexperimental
Clinical trial activity
7 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
5
Earliest trial started Mar 2, 2021 (NCT04945161)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05438251 | Phase 4 | Sep 1, 2022 | China Medical University |
| NCT05317442 | Phase 4 | Mar 30, 2022 | Kaohsiung Medical University, Taipei Medical University |
| NCT05271708 | Phase 4 | Jan 5, 2022 | Government of Taiwan |
| NCT05338463 | Phase 4 | Dec 1, 2021 | Cathay General Hospital |
| NCT04962139 | Phase 3 | Aug 10, 2021 | Oneness Biotech Co., Ltd. |
| NCT05322525 | Phase 4 | Jun 23, 2021 | Taipei Medical University, Taipei Veteran General hospital |
| NCT04945161 | N/A | Mar 2, 2021 | Oneness Biotech Co., Ltd. |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Oneness Biotech Co., Ltd. | For profit | 2 | 2 | 2 | 2021 |
| Taipei Medical University | Academic/Hospital | 2 | 1 | 1 | 2021 |
| Cathay General Hospital | Academic/Hospital | 1 | 1 | 1 | 2021 |
| China Medical University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Government of Taiwan | Government | 1 | 1 | 1 | 2022 |
| Kaohsiung Medical University | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Taipei Veteran General hospital | Government | 1 | 0 | 1 | 2021 |
7 organizations
Page 1 / 1